Maximum urine concentrating ability in children with Hb SC disease: Effects of hydroxyurea

American Journal of Hematology

Volumn 64, Issue 1, 2000, Pages 47-52

  Iyer, Rathi ^a   Baliga, Radhakrishna ^a   Nagel, Ronald L ^c   Brugnara, Carlo ^d   Kirchner, Kent ^b   Hogan, Shirley ^a   Steinberg, Martin H ^a,b  

^a GV (Sonny) Montgomery Veterans Affairs and Administration Hospital   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Dense cells; Hemoglobin C; Hemoglobin SC disease; Hydroxyurea; Hyposthenuria; Sickle hemoglobin

Indexed keywords

DESMOPRESSIN ACETATE; HEMOGLOBIN C; HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; ERYTHROCYTE; FEMALE; HEMOGLOBIN DETERMINATION; HEMOGLOBIN SC DISEASE; HEMOLYSIS; HUMAN; KIDNEY CONCENTRATING CAPACITY; KIDNEY MEDULLA; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; RETICULOCYTE; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTISICKLING AGENTS; CHILD; FEMALE; HEMOGLOBIN SC DISEASE; HUMANS; HYDROXYUREA; KIDNEY CONCENTRATING ABILITY; MALE;

EID: 0034102323     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(200005)64:1<47::AID-AJH8>3.0.CO;2-1     Document Type: Article

References (33)

1. Lawrence C, Fabry ME, Nagel RL. The unique red cell heterogeneity of SC disease: Crystal formation, dense reticulocytes, and unusual morphology. Blood 1991;78:2104-2112.
2. Nagel RL, Lawrence C. The distinct pathobiology of sickle cell-hemoglobin C disease: Therapeutic implications. Hematol Oncol Clin N Am 1991;5:433-451.
3. Bunn HF, Noguchi CT, Hofrichter J, Schechter GP, Schechter AN, Eaton WA. Molecular and cellular pathogenesis of hemoglobin SC disease. Proc Natl Acad Sci USA 1982;79:7527-7531.
4. Ballas SK, Larner J, Smith ED, Surrey S, Schwanz E, Rappaport EF. The xerocytosis of Hb SC disease. Blood 1987;69:124-130.
5. Fabry ME, Kaul DK, Raventos-Suarez C, Chang H, Nagel RL. SC cells have an abnormally high intracellular hemoglobin concentration: Pathophysiological consequences. J Clin Invest 1982;70:1315-1319.
6. Dover GJ. Humphries RK, Moore JG, et al. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production. Blood 1986;67:735-738.
7. Charache S, Dover GJ, Moyer MA, Moore JW. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood 1987;69:109-116.
8. Charache S, Dover GJ, Moore RD et al. Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992;79:2555-2565.
9. Rodgers GP, Dover GJ. Noguchi CT, Schechter AN, Nienhuis AW. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med 1990;322:1037-1045.
10. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995; 332;1317-1322.
11. Bridges K, Barabino G, Brugnara C et al. Hydroxyurea changes SS RBC biochemical/biophysical profile to that of SC RBCs. Blood 1994; 84:41a.
12. Horiuchi K, Hirokawa KJ, Chomo MJ, Ohene-Frempong K. Hydroxyurea inhibits in vitro sickling of reticulocytes. Blood 1996;88:495a.
13. Charache S, Barton FB. Moore RD et al. Hydroxyurea and sickle cell anemia: clinical utility of a myelosuppressive "switching" agent. Medicine (Baltimore) 1996;75:300-326.
14. Steinberg MH, Nagel RL, Brugnara C. Cellular effects of hydroxyurea in Hb SC disease. Br J Haematol 1997;98:838-844.
15. Falk RJ, Jennette JC. Renal Disease. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven-Lippincott; 1994. p 673-680.
16. Statius van Eps LW, Schouten H, Ter Haar Romeny-Wachter CCh, La Porte-Wijsman LW. The relation between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease. Clin Chim Acta 1970;27:501-511.
17. Lesorbe B, Pieron R, Mafart Y, Paillard F, Coudray J, Boulu P. Defaut de concentration urinaire dans la drepanocytose et l'hemoglobinopathie S-C. Etude de 56 sujets. Ann Med Interne 1978;129:289-292.
18. Gupta AK, Kirchner KA, Nicholson R, et al. Effects of α-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait. J Clin Invest 1991;88:1963-1968.
19. Betke K, Marti HR, Schlicht I. Estimation of small percentages of foetal haemoglobin. Nature 1959;184:1887-1888.
20. Brugnara C, Bunn HF, Tosteson DC. Regulation of erythrocyte cation and water content in sickle cell anemia. Science 1986;232:388-390.
21. Brugnara C, Kopin AS, Bunn HF, Tosteson DC. Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest 1985;75:1608-1617.
22. Mohandas N, Kim YR, Tycko DH, Orlik J, Wyatt J, Groner W. Accurate and independent measurement of volume and hemoglobin concentration of individual cells by laser light scattering. Blood 1986;68: 506-513.
23. Brugnara C, Zelmanovic D, Sorette M, Ballas SK, Platt O. Reticulocyte hemoglobin: an integrated parameter for evaluation of erythropoietic activity. Am J Clin Pathol 1997;109:133-142.
24. Kinney TR, Ware RE. Compound heterozygous states. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press; 1994. p 437-451.
25. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
26. Lutty GA, Goldberg MF. Ophthalmologic complications. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven; 1994. p 703-724.
27. Milner PF, Kraus AP, Sebes JI, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 1991;325:1476-1481.
28. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: Incidence and risk factors. Blood 1994;84:643-649.
29. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med 1991;325:11-16.
30. Keitel HG, Thompson D, Itano HA. Hyposthenuria in sickle cell anemia: a reversible renal defect. J Clin Invest 1956;35:998-1007.
31. Statius van Eps LW, Schouten H, La Porte-Wijsman LW, Struyker Boudier AM. The influence of red blood cell transfusions on the hyposthenuria and renal hemodynamics of sickle cell anemia. Clin Chim Acta 1967;17:449-461.
32. Claster S, Vichinsky E. First report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: splenic regeneration. Blood 1996;88:195-203.
33. Bridges KR, Barabino GD, Brugnara C, et al. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood 1996;88:4701-4710.